ERBB2 and breast cancer: Indeed, an altered expression profile of miRNAs can distinguish not only between cancer and healthy samples, but they can classify specific molecular subtypes of BC including HER2, Luminal A (LumA), Luminal B (LumB), and TNBC [6,17].